Discontinuation of Secondary Prophylaxis in Patients with Cytomegalovirus Retinitis Who Have Responded to Highly Active Antiretroviral Therapy

Berenguer, Juan; Gonz á lez, Juan; Pulido, Federico; Padilla, Bel é n; Casado, Jos é Luis; Rubio, Rafael; Arribas, Jos é Rarm ó n
February 2002
Clinical Infectious Diseases;2/1/2002, Vol. 34 Issue 3, p394
Academic Journal
We performed a prospective study of discontinuation of sec-ondary prophylaxis against cytomegalovirus (CMV) in 36 patients with acquired immunodeficiency syndrome and qui-escent CMV retinitis after successful treatment with highly active antiretroviral therapy (HAART). No reactivation or progression of retinitis was observed in 35 patients with per-sistent response to HAART, findings that support the dis-continuation of secondary prophylaxis against CMV retinitis in such patients.


Related Articles

  • Failure of a prospective trial to detect cytomegalovirus retinitis after initiation of highly... Uphold, Constance R.; Smith, Fran // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p907 

    Determines the incidence of cytomegalovirus (CMV) retinis prior to and after initiation with highly active antiretroviral therapy (HAART). Decrease in viral loads and increase in CD4+ T-cell counts after starting HAART; Non-occurrence of CMV retinis among patients receiving HAART; Development...

  • HAART PREVENTS CVM PROGRESSION.  // AIDS Patient Care & STDs;Feb2000, Vol. 14 Issue 2, p101 

    Discloses research findings that patients taking highly active antiretroviral therapy (HAART) regimens may be able to stop taking their anti-CMV medications without progression of retinitis. Ability of HAART to rejuvenate the immune system sufficiently enough to control CMV retinitis without...

  • SELF-REPORTED ADHERENCE NOT RELIABLE.  // AIDS Patient Care & STDs;Jan1999, Vol. 13 Issue 1, p59 

    Reports that self-reporting of adherence to various anti-retroviral therapies is not a reliable method when used alone. Electronic monitoring of adherence.

  • Adherence Assessment to Highly Active Antiretroviral Therapy. Tsasis, Peter // AIDS Patient Care & STDs;Mar2001, Vol. 15 Issue 3, p109 

    Adherence to highly active antiretroviral therapy (HAART) is the outcome of a dynamic process of clinical and behavioral interactions. This article reviews factors influencing this process and provides suggestions to enhance adherence to HAART. Interventions to improve adherence to HAART should...

  • Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS. Crystal, Stephen; Sambamoorthi, Usha; Moynihan, Patrick J.; McSpiritt, Elizabeth; Crystal, S; Sambamoorthi, U; Moynihan, P J; McSpiritt, E // JGIM: Journal of General Internal Medicine;Dec2001, Vol. 16 Issue 12, p850 

    Objective: To examine initiation of newer antiretroviral treatments across sociodemographic subgroups during the 3 years following the introduction of these treatments, and explore persistence on treatment and its association with patient characteristics.Design: Merged...

  • Adherence of Human Immunodeficiency Virus-Infected Patients to Antiretroviral Therapy. Singh, Nina; Berman, Stephen M.; Swindells, Susan; Justis, Janice C.; Mohr, Jeffrey A.; Squier, Cheryl; Wagener, Marilyn M. // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p824 

    Presents a study which assessed the role of demographic, psychosocial and medical-regimen variables on adherence of HIV-infected patients to antiretroviral therapy. Characteristics of the patients; Data and methods used; Results and discussion.

  • Preface of the Special Issue: "Recent CMV Research". Dufrene, Kayla; DeBiasi, Roberta L.; Colberg-Poley, Anamaris M. // Viruses (1999-4915);Jan2014, Vol. 6 Issue 1, p336 

    A preface to the issue is presented where a congenital cytomegalovirus infection patient discusses her struggles with the disease throughout her life and her willingness to learn more about its symptoms, diagnosis, and treatment.

  • CMV implant more effective than IV therapy.  // AIDS Patient Care & STDs;Dec97, Vol. 11 Issue 6, p458 

    States that sustained-release ganciclovir (Cytovene) intraocular implant (Vitrasert) delays the onset of CMV retinitis in people with acquired immunodeficiency syndrome (AIDS), as compared to standard IV therapy. Data published in `New England Journal of Medicine'; Details on the study; What...

  • Cytomegalovirus encephalitis in an HIV positive patient presenting with a cerebral mass lesion. Bassil, Habib F.; William, Daniel C. // AIDS Patient Care & STDs;Oct97, Vol. 11 Issue 5, p319 

    Presents information on Cytomegalovirus (CMV) and how it occurs as an infection in advance AIDS patients. Information on a patient with right-sided weakness due to CMV; Description of similar cases; Diagnoses of CMV.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics